HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tajima, K. Articles by Kawashima, Y. Search for Related Content PubMed PubMed Citation Articles by Tajima, K. Articles by Kawashima, Y.

The Annals of Thoracic Surgery, Vol 55, 625-630, Copyright © 1993 by The Society of Thoracic Surgeons

ARTICLES

Cardiopulmonary bypass and cellular immunity: changes in lymphocyte subsets and natural killer cell activity

K Tajima, F Yamamoto, K Kawazoe, I Nakatani, H Sakai, T Abe and Y Kawashima
Department of Cardiovascular Surgery, National Cardiovascular Center, Suita, Osaka, Japan.

To investigate whether cell-mediated immunity responses are suppressed or activated by the effect of cardiopulmonary bypass (CPB), we studied peripheral blood lymphocyte subsets and antibody-dependent cell- mediated cytotoxicity in 52 adult patients who had undergone open heart operations. Lymphocyte function also was studied with regard to mixed lymphocyte reaction, which indicates the amount of DNA synthesis of lymphocytes, and natural killer (NK) cytotoxicity, which represents the killing activity of NK cells on the tumor cells (K-562), in 11 patients. The total T lymphocyte (OKT3+ and OKT11+) number showed no significant change during CPB. Suppressor/cytotoxic T cell (OKT8+) and NK cell (Leu7+ and Leu11+) numbers were found to be remarkably increased. However, helper/inducer T cell (OKT4+) and B cell (Leu12+) numbers were decreased during CPB. Antibody-dependent cell-mediated cytotoxicity was elevated during CPB. All of these changes were almost returned to the preoperative levels by the seventh day after operation. Mixed lymphocyte reaction and NK cytotoxicity were also activated during CPB. The results show that heart operations in which cardiopulmonary bypass is used are associated with activation of cytotoxic cell-mediated immunity.

This article has been cited by other articles:

				T. Sano, S. Morita, M. Masuda, Y. Tomita, T. Nishida, H. Tatewaki, and H. Yasui Cardiopulmonary bypass, steroid administration, and surgical injury synergistically impair memory T cell function and antigen presentation Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 598 - 602. [Abstract] [Full Text] [PDF]

				M. Wojtalik, W. Mrowczynski, J. Zeromski, and R. Bartkowski Does contegra xenograft implantation evoke cellular immunity in children? Interactive CardioVascular and Thoracic Surgery, September 1, 2003; 2(3): 273 - 278. [Abstract] [Full Text] [PDF]

				D. Lotan, D. Zilberman, O. Dagan, N. Keller, R. Ben-Abraham, A. A. Weinbroum, R. Harel, Z. Barzilay, and G. Paret {beta}-Chemokine secretion patterns in relation to clinical course and outcome in children after cardiopulmonary bypass: continuing the search to abrogate systemic inflammatory response Ann. Thorac. Surg., January 1, 2001; 71(1): 233 - 237. [Abstract] [Full Text] [PDF]

				H. Masuda, Y. Moriyama, R. Toda, S. Shimokawa, Y. Iguro, S.-i. Watanabe, K. Hisatomi, H. Matsumoto, and A. Taira The influence of human T lymphotropic virus type I infection on the outcome of cardiovascular surgery J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 699 - 706. [Abstract] [Full Text] [PDF]

				J. Katoh, K. Tsuchiya, H. Osawa, W. Sato, G. Matsumura, Y. Iida, S. Suzuki, S. Hosaka, S. Yoshii, and Y. Tada Cimetidine reduces impairment of cellular immunity after cardiac operations with cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., August 1, 1998; 116(2): 312 - 316. [Abstract] [Full Text] [PDF]

				H. Mayumi, Q.-W. Zhang, A. Nakashima, M. Masuda, H. Kohno, Y. Kawachi, and H. Yasui Synergistic Immunosuppression Caused by High-Dose Methylprednisolone and Cardiopulmonary Bypass Ann. Thorac. Surg., January 1, 1997; 63(1): 129 - 137. [Abstract] [Full Text]